IGF2BP2 and type 1 diabetes mellitus: The microarray results showed that the expression levels of METTL3 and IGF2BP2 were significantly downregulated, while the expression levels of YTHDC1, HNRNPA2B1 and HNRNPC were significantly upregulated in T1DM patients.